BenevolentAI (AMS: BAI) is a leading developer of advanced artificial intelligence technologies that unlock the value of multimodal data, surface novel insights, and accelerate biomedical discovery.
Through the combined capabilities of its AI platform, its scientific expertise, and wet-lab facilities, the Company is developing an inhouse drug pipeline of high-value assets. The Company is headquartered in London, with a research facility in Cambridge (UK).
Press contacts
ICR Consilium
Amber Fennell/Jessica Hodgson/Ashley Tapp
T: +44(0) 203 709 5700
BenevolentAI@icrinc.com
Useful Links
Images
Sign up for our news